Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$11.23 - $19.59 $112,300 - $195,900
10,000 New
10,000 $138,000
Q1 2022

May 16, 2022

SELL
$13.37 - $17.79 $120,330 - $160,110
-9,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$12.99 - $20.47 $116,910 - $184,230
9,000 New
9,000 $134,000
Q3 2020

Nov 13, 2020

SELL
$39.09 - $53.44 $254,085 - $347,360
-6,500 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$46.7 - $92.04 $303,550 - $598,260
6,500 New
6,500 $311,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.